Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Nomogram Combines Ultrasound Strain Index and Blood Cytokines to Assess Thyroid Metastasis Risk

1 hour ago 3

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

Researchers at Xinxiang Central Hospital have constructed a preoperative predictive nomogram that integrates tissue mechanical measurements from ultrasound elastography with circulating serum immune markers to evaluate the likelihood of central compartment lymph node involvement in adults diagnosed with papillary thyroid carcinoma. Reporting in Frontiers in Oncology, the investigative team analyzed clinical records, standardized sonographic parameters, and baseline cytokine concentrations from a continuous cohort of three hundred and eight patients who underwent thyroidectomy accompanied by central neck dissection between January 2022 and December 2024. The primary objective focused on evaluating whether the ultrasound elastic contrast index alongside circulating concentrations of C-C motif chemokine ligand 20 and interleukin-17A provide independent statistical signals for central nodal spread, ultimately formulating an auxiliary clinical calculation tool designed to assist surgical teams during risk stratification.

Papillary thyroid carcinoma accounts for more than eighty percent of all primary malignant neoplasms identified within the thyroid gland and represents one of the most common malignancies diagnosed in the head and neck region. Despite its typically indolent clinical progression, papillary carcinoma exhibits a notable tendency toward early regional lymphatic dissemination, with occult or clinically evident metastases to the central cervical compartment occurring in thirty to eighty percent of presenting individuals.

To capture distinct biological dimensions of tumor progression without invasive sampling, the investigators evaluated the tissue stiffness parameter known as the elastic contrast index alongside two systemic immune-inflammatory signaling proteins. Tissue biomechanical changes were documented utilizing real-time strain elastography performed on a standardized ultrasound diagnostic platform equipped with a high-frequency linear-array transducer, utilizing intrinsic carotid artery pulsations rather than external manual pressure as the compressive force. The elastic contrast index reflects quantitative hardness differentials established between the primary thyroid lesion and adjacent normal parenchymal compartments, where increased stiffness reflects elevated intratumoral fibrosis, desmoplasia, and cellular packing density. Simultaneously, the researchers quantified baseline circulating concentrations of C-C motif chemokine ligand 20, an immune attractant known to facilitate tumor escape through regulatory T-cell recruitment, and interleukin-17A, a pro-inflammatory cytokine linked to extracellular matrix degradation and lymphangiogenesis, both measured via commercial enzyme-linked immunosorbent assay kits in serum obtained prior to surgical intervention.

The study population was assembled following strict eligibility criteria requiring postoperative histopathological confirmation of papillary thyroid carcinoma, completed thyroid surgery within two weeks of ultrasonography, and comprehensive demographic, imaging, serological, and pathological records without missing data. To satisfy the events per variable standard and mitigate overfitting risks in multivariable modeling, sample size planning incorporated a conservative baseline metastasis incidence of forty percent and an anticipated retention of eight to ten predictive variables, yielding an enrollment requirement exceeding two hundred and fifty individuals. The three hundred and eight qualifying patients were randomly split at a seven-to-three ratio into a derivation cohort comprising two hundred and sixteen individuals and an internal validation subset consisting of ninety-two participants.

Surgical protocols followed standardized institutional paradigms where all patients undergoing total thyroidectomy received routine prophylactic central neck dissection irrespective of preoperative imaging impressions, whereas individuals selected for lobectomy received therapeutic central neck dissection only when suspicious nodal features were identified preoperatively or intraoperatively. Consequently, all participants analyzed in the investigation had documented histopathological evaluation of the central compartment, with a median harvest of eight nodes in the derivation group and seven nodes in the validation cohort. Within the derivation set, one hundred and three patients exhibited pathologically confirmed nodal metastasis while one hundred and thirteen patients remained pathologically node-negative. Baseline demographic and medical variables, including patient age, sex distribution, body mass index, concurrent Hashimoto thyroiditis, tumor location, surgical method, and dissection extent, exhibited no statistically significant differences between metastatic and non-metastatic subgroups, confirming balanced cohort assignment.

Univariable comparisons within the derivation cohort revealed that several primary tumor characteristics appeared significantly more frequent among patients with central nodal metastases. Malignant nodal involvement was associated with higher frequencies of taller-than-wide nodular configuration, multifocal disease, irregular margins, microcalcifications, and ultrasound-detected capsular invasion, alongside significantly greater tumor dimensions and higher elastic contrast index measurements. Correspondingly, baseline biochemical assays demonstrated that patients presenting with metastatic dissemination exhibited significantly elevated mean circulating concentrations of thyroid-stimulating hormone, chemokine ligand 20, and interleukin-17A relative to node-negative counterparts, while circulating thyroid peroxidase and thyroglobulin antibodies, parenchymal echo patterns, and lesional vascular flow showed no significant associations with nodal spread.

Exploratory correlation analyses revealed statistically significant positive interrelationships among the elastic contrast index, chemokine ligand 20, and interleukin-17A, as well as positive correlations between each individual biomarker and thyroid-stimulating hormone, tumor size, nodular margin irregularity, microcalcification presence, and capsular disruption. To isolate genuine independent contributors from collinear imaging indicators, candidate predictors were filtered through penalized LASSO regression utilizing ten-fold cross-validation to locate the optimal shrinkage tuning parameter, which selected eleven influential variables. Subsequent multivariable logistic regression modeling established that eight specific parameters retained independent statistical significance: thyroid-stimulating hormone, primary tumor size, irregular margins, microcalcifications, capsular invasion, elastic contrast index, chemokine ligand 20, and interleukin-17A, whereas taller-than-wide geometry and multifocality lost independent predictive value once direct morphological indicators of invasive potential were accounted for.

Within the final multivariable regression model, irregular margins yielded an adjusted odds ratio of 8.008, while preoperative capsular invasion demonstrated an odds ratio of 6.975 and microcalcifications showed an odds ratio of 3.330. Continuous variables exhibited distinct per-unit and standardized odds ratios reflecting their respective clinical measurement scales: the elastic contrast index registered a per-unit odds ratio of 3.805 and a standardized odds ratio of 2.516 per standard deviation; chemokine ligand 20 showed an odds ratio of 1.213 per nanogram per liter and 5.415 per standard deviation; interleukin-17A registered an odds ratio of 1.346 per picogram per milliliter and 5.875 per standard deviation; and serum thyroid-stimulating hormone demonstrated an odds ratio of 7.924 per unit and 3.134 per standard deviation. Multicollinearity diagnostics confirmed acceptable parameter independence, with variance inflation factors remaining below 1.2 across all included variables.

The eight verified predictors were integrated into a graphical nomogram designed to calculate patient-specific probabilities of central compartment metastasis by allocating weighted point scores proportional to individual regression coefficients. In the derivation cohort, the nomogram demonstrated an apparent area under the receiver operating characteristic curve of 0.960, accompanied by an apparent calibration slope of 1.000 and a Brier score of 0.079. When evaluated in the internal validation cohort of ninety-two patients, the nomogram maintained comparable apparent discrimination with an area under the curve of 0.962, a calibration slope of 0.875, and a Brier score of 0.093. Decision curve analysis conducted across both groups indicated positive net clinical benefit across diagnostic probability thresholds extending from ten percent to eighty percent, suggesting favorable decision-support potential within the evaluated cohort.

The study authors emphasize important methodological considerations and clinical boundaries governing the interpretation of these findings. Because the internal validation set was derived from the same medical center, identical imaging equipment, and matching laboratory staff, it cannot serve as an independent test of model generalizability across diverse institutional practices. Furthermore, internal bootstrap resampling with one thousand iterations yielded an optimism-corrected area under the curve of 0.942 and an adjusted calibration slope of 0.815; however, because the initial LASSO variable screening step was not repeated within individual resamples, this correction represents an optimistic lower bound and true out-of-sample discriminative ability may be lower. Because therapeutic neck dissection was restricted to lobectomy cases with preoperatively suspicious nodes, selection and incorporation biases may also have influenced the observed effect sizes for morphological ultrasound features.

Finally, the authors note that the research assay kits utilized for quantifying chemokine ligand 20 and interleukin-17A currently lack formal in vitro diagnostic regulatory approval and third-party reimbursement, limiting immediate adoption in community settings without specialized cytokine testing infrastructure. The measured single-point elevations in serum thyroid-stimulating hormone and circulating cytokines represent observational associations rather than proven causal drivers of metastasis, and subclinical autoimmune thyroiditis or unmeasured systemic conditions could influence biomarker readings. Consequently, the authors conclude that the nomogram represents an exploratory stratification instrument intended exclusively for patients already selected for central neck dissection, mandating extensive prospective validation across multi-center cohorts with diverse patient demographics before integration into routine surgical workflows.

Subject of Research: Preoperative risk prediction model for central lymph node metastasis in papillary thyroid carcinoma using ultrasound elasticity contrast index and serum biomarkers

Article Title: Risk of central lymph node metastasis in papillary thyroid carcinoma based on ultrasound ECI and serum CCL20 and IL-17A and construction of a nomogram model

Article References: Li, H., Li, J., Dong, T., Yang, X., & Li, Y. (2026). Risk of central lymph node metastasis in papillary thyroid carcinoma based on ultrasound ECI and serum CCL20 and IL-17A and construction of a nomogram model. Frontiers in Oncology, 16, Article 1786471. https://doi.org/10.3389/fonc.2026.1786471

Image Credits: AI Generated

DOI: 10.3389/fonc.2026.1786471

Keywords: Papillary thyroid carcinoma, Central lymph node metastasis, Elastic contrast index, CCL20 chemokine, Interleukin-17A, Nomogram model, Ultrasound elastography, Thyroid cancer staging, Thyrotropin biomarker, Tumor microenvironment, Central neck dissection, Logistic regression modeling, Clinical decision support, Cancer imaging, Thyroid ultrasonography, Predictive oncology

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway